News

AnnJi Pharmaceutical (AnnJi) was awarded the Boehringer Ingelheim “Grass Roots”Support Program for its new drug development project, AJ303.  There are six 6 awardees chosen from 169 applicants, and AnnJi and AJ303 stands out as the only new drug development companies (Source: Boehringer Ingelheim_Taiwan ; News Report: Taipei Times). “Grass Roots” Support Program is a worldwide […]

AnnJi Pharmaceutical (AnnJi) donated to the charitable fundraising activity, “The Great Road Trip”, organized by Kennedy’s Disease-UK (KD-UK) and the Kennedy’s Disease Association (KDA) in the US, to raise awareness of Kennedy’s Disease and to bring funds for research programs. This charity fundraiser was initiated by two former British Royal Navy pilots, both patients of

On 9th, Dec. 2021, Clarivate held a webinar with the main theme “Patient demand is trending the candidate selection for new drug innovation and market entry strategies”, and invited Dr. Wendy Huang, Chair and CEO of AnnJi Pharmaceutical (AnnJi), as the keynote speaker to share her experiences. Dr. Wendy Huang took the histone deacetylase 6

The Annual International SBMA Research Conference sponsored by Kennedy’s Disease Association (KDA) will be held online during October 22-25, 2021. Dr. Michael Y Chan, Ph.D., VP of the Research and Translational Medicine in AnnJi Pharmaceutical Co., Ltd. (AnnJi), is invited to present AnnJi’s research and clinical development plan of AJ201 for the treatment of SBMA. 

ITRI is to hold a webinar on “Mastering Drug Development Trends and Facing New Biomedical Business Opportunities” on October 14, 2021. Biomedical industry professionals and investors are invited to the lectures and discussion on modern developments and business opportunities of new drug treatment. Dr. Chia Hui (Sophia) Wang from AnnJi will speak at the event

AnnJi will be attending BIO-EUROPE Digital 2021, Oct 25-28, to meet with potential pharmaceutical partners and present AnnJi’s development programs of novel small molecule drugs in dermatology and neurology. AnnJi looks forward to meeting with you on the online partneringONE® platform (https://partneringone.informaconnect.com/)!

AnnJi Pharmaceutical Co. is a clinical-stage company focusing on the development of neurological dermatological therapeutics. AnnJi will participate in virtual one-on-one meetings at Digital Bio 2021 held virtually from June 14-18, 2021. The company’s presentation video will be available during the event; featuring AnnJi’s leading assets in the pipeline; such as Nrf2 activator for PolyQ